This makes ritlecitinib the first medicine authorized by the EC to treat individuals with severe alopecia areata as young as 12 years of age.
that evaluated ritlecitinib in patients aged 12 years and older with alopecia areata with 50% or more scalp hair loss, including patients with alopecia totalis and alopecia universalis . Results from this study showed that 13.4% of adults and adolescents achieved 90% or more scalp hair coverage after 24 weeks of treatment with ritlecitinib 50 mg, compared with 1.5% of those on placebo.
The study also measured Patient Global Impression of Change . At week 24, 49.2% of participants treated with ritlecitinib reported a PGI-C response of"moderate" to"great" improvement in their alopecia areata, compared with 9.2% with placebo.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
European Commission authorizes GSK's HIV prevention drugThe European Commission has granted authorization to GSK's HIV-focused division, ViiV Healthcare, for its cabotegravir in both long-acting injectable and tablet forms.
Read more »
Poland proposes ban on Russian diamonds, LPG in new sanctions packageThe Polish proposal will now be considered by the European Commission.
Read more »
Thai cabinet approves higher budget of $97.6 billion for fiscal year 2024 By ReutersThai cabinet approves higher budget of $97.6 billion for fiscal year 2024
Read more »
Hyundai Motor's South Korea union approves wage deal - union official By ReutersHyundai Motor's South Korea union approves wage deal - union official
Read more »
Anchorage Assembly approves contract for legal services in Demboski lawsuitAnchorage Assembly approves contract for legal services in Demboski lawsuit
Read more »
Indonesia parliament committee approves govt's $216.3 billion budget for 2024 By ReutersIndonesia parliament committee approves govt's $216.3 billion budget for 2024
Read more »